Our Grantees

We support partners advancing patient-centered, innovative, evidence-based solutions to make the greatest impact on the crisis. Our grantees are educating health care providers, patients, and the public, developing innovative and effective treatment models, and informing payment and other policies to ensure access to care.

Experiences of Opioid Treatment Programs in Delivering Telemedicine Services During the COVID-19 Pandemic

PI: Sarah Hunter, PhD

Amount: $61,098
Timeline: May – July 2020

Due to the COVID-19 pandemic, many opioid treatment programs (OTP) have had to rapidly transition from in-person care to telemedicine. Researchers at RAND will be conducting a qualitative study to explore providers’ experiences, the different modalities being offered, barriers encountered, and future plans. The study’s findings will inform the ongoing COVID-19 response and elicit lessons learned and policy recommendations for the future of OUD treatment.

Integrating Medications for Opioid Use Disorder into Primary Medical Care: Innovative Payer and Provider Strategies for Improving Treatment Engagement, Retention, Outcomes, and Disparities

PI: Stephen Crystal, PhD

Amount: $525,000
Timeline: February 2020 – 2022

New Jersey’s Medicaid program eliminated prior authorization requirements for buprenorphine, increased reimbursement for intake assessments, and now pays for navigation and peer support services. This evaluation will assess whether these changes have made care more accessible and improved treatment outcomes, helping to inform payers looking for ways to encourage primary care providers to offer medications for opioid use disorder.

Lowering Barriers, Saving Lives, Reclaiming Health: Integrating Medications for Opioid Use Disorder

PI: Lara Weinstein, MD, MPH, DrPH

Amount: $540,676
Timeline: February 2020 – 2022

Thomas Jefferson University’s low barrier medications for opioid use disorder program integrates primary and behavioral health care services, making it easier for the homeless and other marginalized populations to access treatment. In partnership with Project HOME and Pathways to Housing PA, it plans to expand access to the model, study its effectiveness, and offer learning opportunities for resident physicians, medical students, and physician assistant students.

Strategic Plans to Combat Opioid Use Disorder in the State of Alabama

PI: Li Li, MD, PhD

Amount: $410,266
Timeline: March 2020 – 2022

The University of Alabama at Birmingham is using a variety of tools — from educational modules and waiver training to telemedicine consultation — to prepare a cadre of primary care providers at their hospital and in a network of community health centers in Alabama to provide medications for opioid use disorder.

Treatment with Buprenorphine through Telemedicine in a Rural Criminal Justice Setting

PI: Eric Weintraub, MD

Amount: $600,000
Timeline: April 2020 – 2022

Addiction medicine specialists at the University of Maryland will be leveraging telemedicine to deliver medications for opioid use disorder to inmates at three rural detention centers on Maryland’s Eastern Shore and will be working to ensure continuity of care for inmates upon release, when they are at high risk of overdoses.

Jenna's Project: Supporting Women's Re-entry to Society from Prison and Re-connection with Children

PI: Hendrée Jones, PhD

Amount: $428,899
Timeline: March 2020 – September 2021

Jenna’s Project supports women with opioid use disorder who are leaving prison with the aim of helping them avoid overdose and improve their financial stability and independence. The program will introduce women to a treatment and recovery program prior to release and connect them with support and treatment resources for six months to increase their chances for success.